TTC and USciences Sponsors "The State of Clinical Development Costs" Conference in Philadelphia
On January 11-12, 2011 TTC, llc, provider of industry-wide cost benchmarking tools, and the University of the Sciences in Philadelphia (USciences) sponsored the “The State of Clinical Development Costs" conference. Drawing 80 decision makers and specialists from a host of pharmaceutical, biotechnology and medical device companies, and CROs, the 2-day event included two keynote addresses, one by David Fairbrother, Director of Clinical Budgeting at Forest Laboratories, and Hani Zaki, Senior Vice President of PRA International, who spoke on “Future Challenges of Clinical Development; a View from the CRO."
The conference highlighted evidenced based decision-making and research findings. Proceeds from the conference are to be devoted to pursue evidence based research issues that arose during the session. TTC “State of Clinical Development” conference panels addressed a range of topics;“Effective Budgeting and Management of CRO Costs,” “Standard of Care Costs in Clinical Trials, and “Compliance and Fair Market,” “Clinical Trial Costs in Emerging Geographies,” and “Standard of Care Costs in Clinical Trials.”
Additional presentations were given by Dr. Patricia R. Audet on "Productivity and Costs in Today's HealthCare Arena," and by Dr. Laurence Poli of TTC on how CROs and sponsor companies can work together more efficiently.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
